{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:10:52Z","timestamp":1793643052852,"version":"4.5.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>DNA mismatch repair (MMR) deficiency is associated with increased risk of developing several types of cancer and is the most common cause of hereditary endometrial cancer. Identification of the microsatellite instability (MSI) phenotype in endometrial carcinoma is important given that such tumors are frequent.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The objective of this study was to assess the utility of immunohistochemistry (IHC), a simple and fast technique, in detecting MSI status in endometrial carcinoma and evaluate the correlation between the MSI phenotype and the various anatomo-clinical parameters.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>IHC expression of 4 markers (<jats:italic toggle=\"yes\">MLH1<\/jats:italic>, <jats:italic toggle=\"yes\">MSH2<\/jats:italic>, <jats:italic toggle=\"yes\">PMS2<\/jats:italic>, and <jats:italic toggle=\"yes\">MSH6<\/jats:italic>) was studied. For all IHC markers, a combined score based on the intensity of nuclear labeling and the percentage of labeled cells was defined to establish a score. Correlation between MSI phenotype and different clinicopathologic parameters was evaluated using statistical analysis (software STATA and the Fisher exact test).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The mean age of the patients was 58.6 years. Positive staining was highly extended (score 3) with 79% to 100% of marked cells. Less than 10% of positive tumor cells were seen in 3% of cases for <jats:italic toggle=\"yes\">MSH6<\/jats:italic> and <jats:italic toggle=\"yes\">PMS2<\/jats:italic>. Abnormal MMR IHC was detected in 10 cases (22.22%). Seven tumors showed loss of <jats:italic toggle=\"yes\">MLH1<\/jats:italic>\/<jats:italic toggle=\"yes\">PMS2<\/jats:italic>. The loss of <jats:italic toggle=\"yes\">MSH2<\/jats:italic>\/<jats:italic toggle=\"yes\">MSH6<\/jats:italic> was observed in 1 case. The loss of <jats:italic toggle=\"yes\">MLH1<\/jats:italic> or <jats:italic toggle=\"yes\">PMS2<\/jats:italic> was seen only in 2 cases. The number of MSI positive status was 10 cases (22.7%). Correlation between clinicopathologic parameters showed MMR deficiency was significantly associated with low-grade tumor and localized stage. There was no positive correlation between age, histologic subtype, or myometrium invasion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In summary, detection of DNA MMR deficiencies by IHC can effectively diagnose the MSI phenotype in endometrial carcinoma. Correlation between clinicopathologic parameters showed MMR deficiency was significantly associated with low-grade tumor and localized stage.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pai.0000000000000641","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T14:56:30Z","timestamp":1569423390000},"page":"678-682","source":"Crossref","is-referenced-by-count":26,"title":["Mismatch Repair Deficiency in Endometrial Cancer: Immunohistochemistry Staining and Clinical Implications"],"prefix":"10.1097","volume":"27","author":[{"given":"Raoudha","family":"Doghri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoldez","family":"Houcine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Boujelb\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Driss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamia","family":"Charfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Im\u00e8ne","family":"Abbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Mrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Sellami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/PAP.0b013e3182a92cf8","article-title":"Identifying Lynch syndrome in patients with ovarian carcinoma: the significance of tumor subtype","volume":"20","author":"Chui","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ygyno.2013.12.003","article-title":"Mismatch repair deficiency in ovarian cancer molecular characteristics and clinical implications","volume":"132","author":"Xiao","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bulcan.2016.11.006","article-title":"Immunotherapy and patients treated for cancer with microsatellite instability","volume":"104","author":"Colle","year":"2017","journal-title":"Bull Cancer"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00428-004-1090-5","article-title":"The utility of immunohistochemical detection of DNA mismatch repair gene proteins","volume":"445","author":"Shia","year":"2004","journal-title":"Virchows Arch"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.humpath.2010.03.003","article-title":"Interobserver variability in the evaluation ofmismatch repair protein immunostaining","volume":"41","author":"Klarsko","year":"2010","journal-title":"Hum Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/01.pas.0000213428.61374.06","article-title":"Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma","volume":"31","author":"Modica","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ygyno.2015.01.541","article-title":"Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effecively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas","volume":"137","author":"McConechy","year":"2015","journal-title":"Gynecologic Oncol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1525-1578(10)60526-0","article-title":"Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry","volume":"6","author":"Muller","year":"2004","journal-title":"J Mol Diagn"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0000000000000298","article-title":"The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype specific screening strategy","volume":"38","author":"Chui","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1200\/JCO.2015.63.9518","article-title":"Combined microsatellite instability, MLH1 methylation analysis, and immunohistochemistry for lynch syndrome screening in endometrial cancers from GOG210: an NRG Oncology and Gynecologic Oncology Group Study","volume":"33","author":"Paul","year":"2015","journal-title":"J Clin Oncol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2014.01.017","article-title":"Mismatch repair protein expression in 1049 endometrial carcinomas,associations with body max index,and other clinocopathologic variables","volume":"133","author":"JoehlinPrice","year":"2014","journal-title":"Gynecologic Oncol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/PAS.0000000000000663","article-title":"Unusual mismatch repair immunohistochemical patterns in endometrial carcinoma","volume":"40","author":"Watkins","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.humpath.2015.07.009","article-title":"Immunohistochemistry staining for mismatch repair proteins: the endoscopic biopsy material provides useful and coherent results","volume":"46","author":"Vilkin","year":"2015","journal-title":"Hum Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10689-013-9612-4","article-title":"Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry","volume":"12","author":"Shia","year":"2013","journal-title":"Fam Cancer"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2015.11.032","article-title":"Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas","volume":"140","author":"Shikama","year":"2016","journal-title":"Gynecologic Oncol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","article-title":"Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncr.21560","article-title":"Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma","volume":"106","author":"Broaddus","year":"2006","journal-title":"Cancer"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1200\/JCO.2005.04.1574","article-title":"Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma","volume":"24","author":"Black","year":"2006","journal-title":"J Clin Oncol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0046-8177(98)90430-0","article-title":"Microsatellite instability in endometrial carcinomas clinicopathologic correlations in a series of 42 cases","volume":"29","author":"Catasus","year":"1998","journal-title":"Hum Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/gyno.1999.5351","article-title":"Microsatellite instability in endometrial cancer: relation to histological subtypes","volume":"73","author":"Tibiletti","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1200\/JCO.2006.08.2107","article-title":"Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type","volume":"25","author":"Zighelboim","year":"2007","journal-title":"J Clin Oncol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ygyno.2009.05.026","article-title":"Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer","volume":"114","author":"Backes","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R23-20230922","first-page":"1671","article-title":"Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma","volume":"148","author":"Caduff","year":"1996","journal-title":"Am J Pathol"},{"key":"R24-20230922","first-page":"556","article-title":"Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas","volume":"55","author":"Katabuchi","year":"1995","journal-title":"Cancer Res"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/01.pas.0000126720.49083.11","article-title":"More differences between HNPCC-related and sporadic carcinomas from the endometrium as compared to the colon","volume":"28","author":"Van den Bos","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R26-20230922","first-page":"417","article-title":"Favorable survival associated with microsatellite instability in endometrioid endometrial cancers","volume":"97","author":"Maxwell","year":"2001","journal-title":"Obstet Gynecol"}],"container-title":["Applied Immunohistochemistry &amp; Molecular Morphology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAI.0000000000000641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:13:22Z","timestamp":1695406402000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAI.0000000000000641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pai.0000000000000641","relation":{},"ISSN":["1541-2016"],"issn-type":[{"value":"1541-2016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}